The global vascular grafts market is set to witness rapid growth on account of increasing incidence of vascular disorders. This information has been provided by Fortune Business Insights, titled “Vascular Grafts Market Size, Share and Global Trend By Product Type (Endovascular Stent Graft, Hemodialysis Access Graft, Bypass Graft, Peripheral Vascular Graft), By Application (Coronary Artery Disease, Vascular Occlusion, Renal Failure), By Material (Synthetic, Biological), By End User (Hospitals, Specialty Clinics), and Geography Forecast till 2026”.
The report provides a study and analysis of the various factors that are likely to accelerate the growth of the global vascular grafts market.
Vascular graft or bypass is a widely accepted and recommended surgical procedure. It is performed to redirect blood flow from one area of the body to another by reconnecting the blood vessels. The most common condition that requires the use of a vascular graft is ischemia (inadequate blood supply) caused by arteriosclerosis. In such conditions, a vascular graft is the best solution to restore regular blood circulation in the body.
Get Sample PDF:
Top Leaders Overview:
Some of the leading companies in the global Vascular Grafts Market:
- Artegraft, B. Braun Melsungen, BD
- Cook Medical
- CryoLife, Inc
- Heart Medical
- LeMaitre Vascular
- MAQUET getinge group
- Shanghai Suokang Medical Implants
- Vascular Grafts Solutions
“Rising Incidence of Cardiovascular Diseases to Fuel the Market”
Cardiovascular diseases are widely accepted as one of the leading causes of death worldwide, according to a report by the World Health Organization. In a report of similar nature, the Centre for Disease Control and Prevention revealed that coronary heart disease is the most common form of heart that kills millions of Americans every year.
Besides coronary heart disease, Peripheral Artery Diseases (PAD) and cerebrovascular diseases are the major causes of cardiovascular diseases in the world. The rising number of cases related to such diseases in both the developed and developing nations is expected to aid the rapid growth of the global vascular grafts market in the forecast period.
Primary reasons for the steady rise in cardiovascular diseases are adoption of unhealthy lifestyles (for example, excessive consumption of fatty foods, sedentary habits etc.), hypertension and high blood sugar levels. The global vascular grafts market is anticipated to gain traction as a result of these factors.
Browse Complete Report:
“Expensive Surgeries a Major Roadblock”
While there are many factors favoring the expansion of the global vascular grafts market, it still has to overcome certain obstacles. One such obstacle is the high cost of surgeries required to treat vascular disorders. The other major roadblock is the fear of vascular graft infection. Though rare, the possibility of occurrence of vascular graft infections instils an element of distrust among the afflicted. According to a paper published by the Khakiv National Medical University in Ukraine, if a vascular graft infection occurs, it can prove disastrous for the patient. Such infections can lead to amputation or death, the paper notes.
Thus, these factors can prove to be major hindrances in the growth and development of the global vascular grafts market.
“Exciting Investment Opportunities Attracting Serious Players”
Seeing the scope of the rapidly developing global vascular grafts market, major players are entering the field and elevating the competition levels. Most of them are focusing on investing in R & D projects and developing and launching innovative products to diversify their portfolios.
For example, Cardiovate, a start-up, developed and patented the first ever bio-absorbable vascular graft. It is designed to improve blood flow and prevent amputations. In January 2019, Somahlution released a clinical study stating that DuraGraft lowers the risk of post coronary bypass grafting.
Some of the key players identified by Fortune Business Insights in this market include CryoLife, Vascular Grafts Solutions, Cook Medical, Artegraft, LeMaitre Vascular, and others.
“Asia-Pacific Expected to Exhibit Higher CAGR in the Forecast Period”
While North America continues to hold the largest share in the global vascular grafts market, Asia-Pacific is slated to register a relatively higher CAGR between 2018 and 2026. This is mainly attributable to government-led awareness initiatives in developing countries about treatment of chronic diseases, increased government spending on public health, deeper penetration of technology in the healthcare sector, and greater R & D investment to develop early detection devices. The global vascular grafts market is anticipated to grow owing to the combined effect of these drivers.
Segmentation of the Global Vascular Grafts Market
By Product Type
- Endovascular Stent Graft
- Hemodialysis Access Graft
- Bypass Graft
- Peripheral Vascular Graft
- Coronary Artery Disease
- Vascular Occlusion
- Renal Failure
Speak to Analyst:
Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We therefore offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Fortune Business Insights Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune – 411045, Maharashtra, India.
US: +1 424 253 0390
UK: +44 2071 939123
APAC: +91 744 740 1245